Heart Failure Clinical Trials
148 studies are recruiting for heart failure in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 4
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them wo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Jia-Rong Wu, Lexington, Kentucky
- Run by
- Jia-Rong Wu
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Peak Heart and Vascular, Avondale, Arizona
- Locations
- 12 in total
- Run by
- VDI Technologies
-
Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction
Heart failure (HF) affects more than 6 million adults in the U.S. alone, with increasing prevalence. Cardiovascular congestion with resultant limitation in physical activity is the hallmark of chronic and decompensated HF. The current HF physiologic model suggests that congestion is the result of v…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Duke, Durham, North Carolina
- Run by
- Duke University
-
The Salt Study for Heart Failure
The purpose of this study is to understand if low sodium (cardiac) diet is indeed necessary for better health outcomes in patients who suffered heart failure. This study will investigate the association between sodium intake and risk for 30-day re-admission in Heart Failure (HF) patients.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Robert Wood Johnson Barnabas Hospital - New Brunswick, New Brunswick, New Jersey
- Run by
- Maya Guglin, MD
-
Cardiovascular Health Improvement Project
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
- Stage
- Not phased
- Ages
- Any age
- Site
- University of Michigan, Ann Arbor, Michigan
- Run by
- University of Michigan
-
CCM OPEN HF Registry
The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cardiovascular Associates of Mesa, Mesa, Arizona
- Locations
- 28 in total
- Run by
- Impulse Dynamics
-
A Study of Paramedic HF Management
The purpose of this research is to see if having community paramedic (CP) visit patients at home to manage their heart failure help them stay out of the hospital and improve their overall health compared to standard care. The investigators want to find out if their approach is better for patients i…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Promoting Well-being and Health in Heart Failure
The focus of this study is to test the efficacy of a 12-week, phone-delivered Positive Psychology-Motivational Interviewing (PP-MI) intervention, with additional twice weekly PP and health behavior text messages for a total of 24 weeks (with interactive, algorithm-driven, goal-focused text messages…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert, Arizona
- Locations
- 92 in total
- Run by
- Cardiac Dimensions, Inc.
-
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of breath, fluid retention, and fatigue. HeartShare aims to better classify heart failure into subtypes …
- Stage
- Not phased
- Ages
- 30 and older
- Site
- University of California Davis, Sacramento, California
- Locations
- 6 in total
- Run by
- Northwestern University
-
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor (www.alivecor.com) has developed several electrocardiogram (ECG) devices that interface with iOS and Android smartphones and tablets via various Kardia apps. The current Kardia family of devices can measure single lead and six limb-lead ECGs, depending on the device. KardiaMobile, KardiaMo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 4 in total
- Run by
- AliveCor
-
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new trea…
- Stage
- Not phased
- Ages
- 30 and older
- Site
- Northwestern University, Chicago, Illinois
- Locations
- 6 in total
- Run by
- Northwestern University
-
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. The main questions i…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Lakeland Regional Hospital, Lakeland, Florida
- Run by
- Lakeland Regional Health Systems, Inc.
-
CardioMEMS HF System Coverage With Evidence Development Study
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Abbott, Pleasanton, California
- Run by
- Abbott Medical Devices
-
Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
The investigators will conduct a two-phase pilot study to test the feasibility and acceptability of a 12-week Chair Yoga intervention for 20 heart-failure patients. Using a patient-centered approach, investigators will involve stakeholders in designing the protocol, gather patient feedback, and ref…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Auburn University, Auburn, Alabama
- Run by
- Auburn University
-
Precision Rehabilitation for Veterans With (HFpEF)
This study is being completed because there is conflicting information regarding the value of monitored exercise in patients with heart failure with preserved ejection fraction (HFpEF). The purpose of this study is to collect baseline information necessary for researchers to pursue a larger study e…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Columbia VA Health Care System, Columbia, South Carolina
- Run by
- Columbia VA Health Care System
-
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because …
- Stage
- Phase 3
- Ages
- 18 to 75
- Site
- Stanford University Medical Center, Stanford, California
- Locations
- 19 in total
- Run by
- Alessandro Doria
-
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UC San Diego Health, La Jolla, California
- Locations
- 14 in total
- Run by
- XVIVO Perfusion
-
Home Hospital for Suddenly Ill Adults
The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and impro…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- Brigham and Women's Hospital
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Inova Fairfax Medical Campus, Falls Church, Virginia
- Run by
- Inova Health Care Services
-
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
Heart failure (HF) is a growing health and economic burden around the globe, and it remains a leading cause of morbidity and mortality among the general population. HIV is recognized as an independent risk factor for HF, due to direct and indirect effects. Furthermore, people living with HIV (PLWH)…
- Stage
- Not phased
- Ages
- 40 and older
- Site
- University of Washington, Seattle, Washington
- Locations
- 2 in total
- Run by
- University of Washington
-
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
The overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care in hospitalized patients with heart failure associated acute kidney injury is safe and efficacious. Investigators will assess if SGLT2 inhibition improves a composite cardio-renal outcome (mor…
- Stage
- Phase 2
- Ages
- 18 to 85
- Site
- Yale New Haven Hospital-St. Raphael Campus, New Haven, Connecticut
- Locations
- 2 in total
- Run by
- Yale University
-
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
This is a single-center, non-randomized study.The study staff will use the InSpectraTM tissue oxygen saturation (StO2) monitor manufactured by Hutchinson Technology to measure baseline StO2 levels after applying the noninvasive probe to the thenar eminence. After a stable reading is obtained, a blo…
- Stage
- Not phased
- Ages
- Up to 25
- Site
- University of Florida, Gainesville, Florida
- Run by
- University of Florida
-
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Yale New Haven Health System, New Haven, Connecticut
- Run by
- Yale University
-
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients ac…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of California, San Francisco (UCSF), San Francisco, California
- Locations
- 3 in total
- Run by
- Noah Labs
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.